APA (7th ed.) Citation

Redner, R. L., Beumer, J. H., Kropf, P., Agha, M., Boyiadzis, M., Dorritie, K., . . . Johnson, D. E. (2018). A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia. Leukemia & Lymphoma, 59(11), 2595. https://doi.org/10.1080/10428194.2018.1443330

Chicago Style (17th ed.) Citation

Redner, Robert L., et al. "A Phase-1 Study of Dasatinib Plus All-trans Retinoic Acid in Acute Myeloid Leukemia." Leukemia & Lymphoma 59, no. 11 (2018): 2595. https://doi.org/10.1080/10428194.2018.1443330.

MLA (9th ed.) Citation

Redner, Robert L., et al. "A Phase-1 Study of Dasatinib Plus All-trans Retinoic Acid in Acute Myeloid Leukemia." Leukemia & Lymphoma, vol. 59, no. 11, 2018, p. 2595, https://doi.org/10.1080/10428194.2018.1443330.